Developments, news and strategies for drug development specific to phase I through Phase III global clinical trial management, execution, project management and outsourcing. Go→
News, articles and issues specific to clinical trial practice and implementation at the investigative site level. Go→
News, developments and strategies related to eClinical, data management, data collection, ePRO, and more information technology used in the drug development chain. Go→
News, articles and issues specific to laboratories role in the clinical trial, including ECG, imaging, genotyping, tissue samples and more. Go→
News, developments and strategies for clinical trials conduct in relation to the FDA, EMEA and other global regulatory authorities overseeing the drug development industry. Go→
News, articles and strategies related to clinical trial design which impact postmarketing studies, therapeutic areas, adaptive trials, statistics, protocols and more. Go→
|
See our 2012 Buyers Guide Digital Edition.
 
|
Pfizer is one of three organizations whose accreditation was approved by the AAHRPP Council on Accreditation in March. Others include a healthcare network in Connecticut and an independent institutional review board in Maryland. The newly accredited organizations are: · Hartford HealthCare, Hartford, Conn. · MaGil IRB Inc., Rockville, Md. · Pfizer Inc., New York, N.Y. The accreditation of Pfizer—the world’s largest research-based pharmaceutical company and the first major commercial research sponsor to attain AAHRPP accreditation— is expected to have global repercussions. In 2009, Pfizer became the first pharmaceutical company to earn AAHRPP accreditation for its phase I clinical research units, which are located in New Haven, Conn.; and Brussels, Belgium. The current accreditation applies to all of Pfizer’s phase 2 through 4 clinical trials. “AAHRPP accreditation affirms that Pfizer provides a higher level of protection for research participants regardless of where they live or the type of trial involved,” said Marjorie A. Speers, Ph.D., AAHRPP president and CEO. “Thousands of Pfizer researchers worldwide are conducting research in accordance with the ‘gold standard’ for quality and ethics,” Speers added. “That raises the bar and sets an example for other sponsors to follow.” AAHRPP accreditation is available to U.S. and international organizations that conduct biomedical, behavioral or social sciences research involving human participants. To date, AAHRPP has accredited organizations in 46 states, Canada, China, India, Korea, Singapore and Taiwan.
|
|
|
|
|
Facebook
Quizzes
